Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark W. Kroll currently holds 24,757 shares of HAEMONETICS CORP (HAE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark W. Kroll has been a net seller of HAE stock. They have purchased $98.8K and sold $9.9M worth of shares.
Mark W. Kroll's most recent insider trade was on Nov 10, 2025, when they purchased 1,400 shares at $70.56 per share.
Mark W. Kroll serves as Executive at HAEMONETICS CORP (HAE). They have executed 114 insider transactions totaling $10.0M over their tenure at the company.
Mark W. Kroll holds the position of Executive at HAEMONETICS CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Mark W. Kroll has shown a selling trading pattern, with $98.8K in total purchases and $9.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark W. Kroll was on Nov 7, 2018, when they sold $1.2M worth of HAE shares. This transaction involved 10,707 shares at $114.00 per share.
Mark W. Kroll currently owns 24,757 shares of HAEMONETICS CORP (HAE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark W. Kroll's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark W. Kroll has 114 Form 4 filings on record as an insider at HAEMONETICS CORP.
Set alerts for Mark W. Kroll and 40,000+ other insiders.